The Future of Pharma Pricing, Access, and Global Market Complexity

Send us Fan Mail Jesse Mendelsohn and Michael Grosberg from Model N discuss why U.S. pricing complexity is spreading globally, the collapse of the PBM rebate model, what's really driving the pharmaceutical manufacturing boom, and why direct-to-consumer discount programs won't solve America's drug access problem. 00:00 Introduction to Life Science Success Podcast 00:34 Pressing Issues in Pharmaceutical Manufacturing 00:51 Introducing the Experts from Model N 03:08 Understanding International Reference Pricing 04:14 Impact of US Pricing on Global Drug Launches 09:26 Challenges with Pharmacy Benefit Managers 16:29 Domestic Manufacturing Boom in Pharmaceuticals 23:08 AI in Drug Discovery and Personalized Medicine 29:03 Access and Policy Discussion 30:01 Direct to Consumer Pricing 31:32 TrumpRx Overview 33:11 Compliance Challenges 38:30 Pharmaceutical Revenue Management 41:38 AI in Life Sciences 48:35 Future of Life Sciences 50:45 Concerns and Challenges 53:52 Excitement in Current Work 55:54 Conclusion and Final Thoughts

You can listen to The Future of Pharma Pricing, Access, and Global Market Complexity online on Radio and Podcast. Open the player on this page to stream the available audio.

The Future of Pharma Pricing, Access, and Global Market Complexity is an episode from Life Science Success by Don Davis PhD, MBA.

This episode is 57:11 long.

This episode was published on Jan 29, 2026.

Yes. Use the heart button on the episode page to add it to your favorite episodes list.

Yes. This page shows related episodes from Life Science Success when more episodes are available from the podcast feed.